中国药房2017，Vol.28Issue(26)：3620-3623,4.DOI:10.6039/j.issn.1001-0408.2017.26.06
浙江省11家医院2010-2015年乳腺癌患者内分泌治疗药物应用分析
Analysis of the Utilization of Endocrine Therapy Drugs in Breast Cancer Patients from 11 Hospitals of Zhe-jiang Province during 2010-2015
孙娇 1孔思思 1郑小卫 1张轶雯 1方罗1
作者信息
- 1. 浙江省肿瘤医院药剂科,杭州 310022
- 折叠
摘要
Abstract
OBJECTIVE:To investigate the status quo and tendency of endocrine therapy drugs in breast cancer patients from 11 hospitals of Zhejiang province during 2010-2015. METHODS:The prescriptions of breast cancer patients in 11 hospitals of Zhe-jiang province were analyzed retrospectively in respects of consumption sum,DDDs,DDC,etc. RESULTS:The consumption sum of endocrine therapy drugs in breast cancer patients from 11 hospitals of Zhejiang province during 2010-2015 increased from 2530192.33 yuan to 6201691.54 yuan,and its proportion in total consumption sum increased from 13.93％ to 17.40％,showing in-creasing tendency. The anastrozole always took up the first place in the list of consumption sum. Tamoxifen,anastrozole and letro-zole took up the top 3 places in the list of DDDs. Goserelin took up the first place in the list of DDC. CONCLUSIONS:The pre-scription amount and consumptionsum of endocrine therapy drugs in breast cancer patients from 11 hospitals of Zhejiang province during 2010-2015 show year-on-year growth trend;and those drugs which are safe,effective,economical and convenient predomi-nate in clinic.关键词
内分泌治疗药物/乳腺癌/销售金额/用药频度/日均费用/用药分析Key words
Endocrine therapy drugs/Breast cancer/Consumption sum/DDDs/DDC/Analysis of drug use分类
医药卫生引用本文复制引用
孙娇,孔思思,郑小卫,张轶雯,方罗..浙江省11家医院2010-2015年乳腺癌患者内分泌治疗药物应用分析[J].中国药房,2017,28(26):3620-3623,4.
